Autistic Disorder: Clinical Trials

68 trials for Autistic Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

47 completed, 5 terminated, 5 unknown, 4 not yet recruiting. 68 Phase 1, 24 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 168Completed 47, Terminated 5, Unknown 5, Not yet recruiting 4, Recruiting 4, Withdrawn 2, Enrolling by invitation 1
Phase 224Completed 14, Unknown 4, Not yet recruiting 3, Enrolling by invitation 1, Terminated 1, Withdrawn 1

Follow Autistic Disorder: new trials by email Literature Review of Autistic Disorder trials Research Report on Autistic Disorder

Trials (filtered) newest first · largest first

All 68 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders
Fecal Microbiota Transplant - Autism, Autism Spectrum Disorder
Phase 1Not yet recruitingProgenaBiome102027-05-012026-09-18
GAIP ASD Research Study
Umbilical Cord Blood-Derived Stem Cells and Exosomes, Glutathione - Autism Spectrum Disorder, Autism
Phase 1RecruitingGreater Atlanta Integrative Pediatrics1002026-06-012026-06-03
Adia Med of Winter Park LLC Autism Spectrum Disorder Research Study
Umbilical Cord Blood-Derived Stem Cells and Exosomes, Glutathione - Autism Spectrum Disorder, Autism
Phase 1RecruitingAdia Med of Winter Park LLC1002026-05-012026-09-22
Autism Spectrum Disorder (ASD) Neurodevelopmental Disorder With Issues Social Behavior, Communication Issues, GI Dysfunction. Study is Multimodal Interventions Targeting These Pathways With cSVF, Stored MSCs, FMT and Diet Modification. Role of Autoimmunity, Gut-brain Issues, & Issues Examined.
Autologous MSC isolation, concentration, and cryopreservation of adult mesenchymal stem cells, Fecal Biomicrome Transplantation (FMT), Ketogenic RESET Diet Protocol - Autism Spectrum Disorder, Autism
Phase 1 / Phase 2Enrolling by invitationBlack Tie Medical, Inc.502026-04-302026-04-27
Xenon Therapy for Children With Autism Spectrum Disorder
Xenon - Autism Spectrum Disorder (ASD), Autism
Phase 1 / Phase 2Not yet recruitingThe Children's Hospital of Zhejiang University School of Medicine722026-03-012026-02-27
Enhancing Orthographic Communication and Literacy Outcomes for AAC Learners
ALLSTAR - Literacy, Communication, Nonverbal
Phase 1 / Phase 2Not yet recruitingPenn State University602026-03-012026-02-03
Treatment Planning for ABA Employing Auxiliary Tools V2+ (TREAAT2+)
Tech-enabled ABA treatment planning - Autism Spectrum Disorder
Phase 1 / Phase 2Not yet recruitingMontera Health Texas LLC202025-07-012024-11-22
Allogeneic Wharton Jelly Mesenchymal Stromal Cell (WJMSC) for Treatment of Autism
WJMSC - Autism
Phase 1RecruitingUniversity of Jordan142022-03-092025-01-24
hCT-MSC Infusion in Adults With Autism Spectrum Disorder
hCT-MSC - Autism Spectrum Disorder, Autism
Phase 1CompletedJoanne Kurtzberg, MD82022-01-242024-07-23
Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for Autism
cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells - Autism
Phase 1RecruitingThe Foundation for Orthopaedics and Regenerative Medicine152022-01-232026-10-20
28-Day Daily-dose Crossover Study of the Safety and Tolerability of SB-121 (Lactobacillus Reuteri With Sephadex® and Maltose) in Subjects, Ages 15 to 45 Years, Diagnosed With Autistic Disorder
SB-121, Placebo - Autistic Disorder
Phase 1CompletedScioto Biosciences, Inc.152021-08-022024-03-25
Open Label Phase I hCT-MSC in Toddlers With Autism Spectrum Disorder
hCT-MSC infusion - Autism Spectrum Disorder
Phase 1CompletedDuke University122021-02-242025-02-24
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants
RO6953958, Placebo, Midazolam - Autistic Disorder, Autism Spectrum Disorder
Phase 1CompletedHoffmann-La Roche882020-07-152024-07-10
Cariprazine Pediatric ASD PK Study
Cariprazine - Autism Spectrum Disorder
Phase 1CompletedAbbVie242020-06-262022-04-12
Investigation of Mechanisms of Action in Superpower Glass
Superpower Glass - Autism Spectrum Disorder, Autism
Phase 1 / Phase 2TerminatedStanford University202019-09-042023-09-05
Safety and Efficacy of the Transfusion of UCB in Patients With an ASD Depending on the Degree of HLA Compatibility.
ASD CB-MNC infusion low level HLA compatibility., ASD CB-MNC infusion high level HLA compatibility., Standard therapy. - Autism Spectrum Disorder, Autism
Phase 1 / Phase 2UnknownState-Financed Health Facility "Samara Regional Medical Center Dinasty"1502019-08-102023-01-18
A Proof-of-Concept Study of Minocycline in Autism
Minocycline, Placebos - Autism Spectrum Disorder, Autism
Phase 1CompletedChildren's Hospital Medical Center, Cincinnati532019-04-192020-12-08
Allogenic Cord Blood Transfusion in Patients With Autism
ASD CB-MNC injection., Standard therapy. - Autism Spectrum Disorder, Autism
Phase 1 / Phase 2CompletedState-Financed Health Facility "Samara Regional Medical Center Dinasty"202018-10-122020-11-19
Trial to Assess the Pharmacokinetics, Safety, Tolerability of Oral Brexpiprazole in Children (6 to <13 Years Old) With Central Nervous System Disorders
Brexpiprazole - ADHD, Autism
Phase 1CompletedOtsuka Pharmaceutical Development & Commercialization, Inc.242017-10-102018-06-12
RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome
RAD001, Placebo - PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome
Phase 1 / Phase 2CompletedBoston Children's Hospital462017-06-122025-02-17

Showing 20 of 68. Sign in to see all of them.

Narrower conditions

Autism Spectrum Disorder (24)  ·  Child Development Disorders, Pervasive (8)  ·  Asperger Syndrome (4)  ·  Intellectual Disability (3)  ·  Anxiety Disorders (2)  ·  Communication (2)  ·  Down Syndrome (2)  ·  Fragile X Syndrome (2)  ·  Learning Disabilities (2)  ·  Neurodevelopmental Disorders (2)  ·  Aggression (1)  ·  Attention Deficit Disorder with Hyperactivity (1)  ·  Brain Injuries (1)  ·  Central Nervous System Diseases (1)

Broader conditions

Mental Disorders (67)  ·  Neurodevelopmental Disorders (66)  ·  Child Development Disorders, Pervasive (60)  ·  Autism Spectrum Disorder (44)  ·  Nervous System Diseases (9)  ·  Neurobehavioral Manifestations (7)  ·  Neurologic Manifestations (7)  ·  Behavior (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Genetic Diseases, Inborn (5)  ·  Signs and Symptoms (5)  ·  Congenital Abnormalities (4)  ·  Abnormalities, Multiple (3)  ·  Chromosome Disorders (3)

Interventions

Oxytocin (5)  ·  Cognitive Behavioral Therapy (2)  ·  Fecal Microbiota Transplantation (2)  ·  Glutathione (2)  ·  Hyperbaric Oxygenation (2)  ·  Risperidone (2)  ·  Standard of Care (2)  ·  (6-chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1H-isobenzofuran-3,4'-piperidine)-1'-yl-methanone (1)  ·  3-(2,4-dimethoxybenzylidene)anabaseine (1)  ·  Acamprosate (1)  ·  Anti-Inflammatory Agents (1)  ·  Buspirone (1)  ·  Cholesterol (1)  ·  Citalopram (1)  ·  Donepezil (1)

Sponsors

Children's Hospital Medical Center, Cincinnati (5)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (2)  ·  Hoffmann-La Roche (2)  ·  Joanne Kurtzberg, MD (2)  ·  National Institute of Mental Health (NIMH) (2)  ·  State-Financed Health Facility "Samara Regional Medical Center Dinasty" (2)  ·  University of North Carolina, Chapel Hill (2)  ·  AbbVie (1)  ·  Adia Med of Winter Park LLC (1)  ·  Ageless Regenerative Institute (1)  ·  Alliant International University (1)  ·  Anagnostou, Evdokia, M.D. (1)  ·  Black Tie Medical, Inc. (1)  ·  Boston Children's Hospital (1)  ·  Chaitanya Hospital, Pune (1)

Countries

United States (50)  ·  Brazil (2)  ·  China (2)  ·  Russia (2)  ·  United Kingdom (2)  ·  Canada (1)  ·  France (1)  ·  Greece (1)  ·  India (1)  ·  Israel (1)  ·  Jordan (1)  ·  Norway (1)  ·  Panama (1)  ·  Taiwan (1)  ·  Thailand (1)

Top investigators

Jessica Sun, MD (3)  ·  Joanne Kurtzberg, MD (3)  ·  Geraldine Dawson, PhD (2)  ·  Abdallah Awidi, MD (1)  ·  Alan S Lewis, MD, PhD (1)  ·  Alexander Vinks, Pharm.D., Ph.D. (1)  ·  Allen Song, PhD (1)  ·  Alvaro Pascual-Leone, M.D. Ph. D. (1)  ·  Ana Carina Tamanaha, Student (1)  ·  Andrew Wakefield, MD (1)  ·  Anett Kaale, PhD student (1)

Results publications

PMID 37811711, PMID 16554123, PMID 19948568, PMID 20145986, PMID 20680427, PMID 21883204, PMID 22537359, PMID 22588377, PMID 23978163, PMID 24439092, PMID 24472253, PMID 25526831, PMID 26631428, PMID 27711048, PMID 30230399, PMID 33473111, PMID 34693989, PMID 35594551, PMID 36997569

NIH funding

2019 (1), K01MH079945 (1), K23MH081285 (1), R34HD065274 (1), U54HD079124 (1), U54MH066397 (1), U54MH066399 (1), U54NS092090 (1)